+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Obsessive-compulsive Disorder Drugs Market 2025-2029- Product Image
Obsessive-compulsive Disorder Drugs Market 2025-2029- Product Image
New

Obsessive-compulsive Disorder Drugs Market 2025-2029

  • PDF Icon

    Report

  • 217 Pages
  • March 2025
  • Region: Global
  • TechNavio
  • ID: 5606268
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The obsessive-compulsive disorder drugs market is forecasted to grow by USD 395.3 million during 2024-2029, accelerating at a CAGR of 6.3% during the forecast period. The report on the obsessive-compulsive disorder drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of OCD, launch of new molecules, and increasing awareness programs for OCD.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The obsessive-compulsive disorder drugs market is segmented as below:

By Product

  • SSRI
  • TCA
  • Others

By Route Of Administration

  • Oral
  • Parentral

By Therapy

  • Cognitive behavioral therapy
  • Augmentation therapy
  • Aversion therapy
  • Systematic desensitization
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increased use of off-label therapies as one of the prime reasons driving the obsessive-compulsive disorder drugs market growth during the next few years. Also, expanding research on first-in-class peptide therapeutics and increasing generic approvals will lead to sizable demand in the market.

The report on the obsessive-compulsive disorder drugs market covers the following areas:

  • Obsessive-Compulsive Disorder Drugs Market sizing
  • Obsessive-Compulsive Disorder Drugs Market forecast
  • Obsessive-Compulsive Disorder Drugs Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading obsessive-compulsive disorder drugs market vendors that include Alembic Ltd., Anant Pharmaceuticals Pvt. Ltd., Apotex Inc., BrainsWay Ltd., Dellwich Healthcare LLP, Eli Lilly and Co., Eridanus Healthcare, Flamingo Pharmaceuticals Ltd., GlaxoSmithKline PLC, H Lundbeck AS, Jabs Biotech Pvt. Ltd., Jazz Pharmaceuticals PLC, Kabir Life Sciences, Lepu Medical Technology Beijing Co. Ltd., Lifecare Neuro Products Ltd., Novartis AG, Pfizer Inc., and Wellona Pharma. Also, the obsessive-compulsive disorder drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by Therapy
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Obsessive-Compulsive Disorder Drugs Market 2019 - 2023
Historic Market Size - Data Table on Global Obsessive-Compulsive Disorder Drugs Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.4 Therapy segment analysis 2019 - 2023
Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI in Global Obsessive-Compulsive Disorder Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
8.1 Market segments
Chart on Product - Market share 2024-2029 (%)
Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
8.3 SSRI - Market size and forecast 2024-2029
Chart on SSRI - Market size and forecast 2024-2029 ($ million)
Data Table on SSRI - Market size and forecast 2024-2029 ($ million)
Chart on SSRI - Year-over-year growth 2024-2029 (%)
Data Table on SSRI - Year-over-year growth 2024-2029 (%)
8.4 TCA - Market size and forecast 2024-2029
Chart on TCA - Market size and forecast 2024-2029 ($ million)
Data Table on TCA - Market size and forecast 2024-2029 ($ million)
Chart on TCA - Year-over-year growth 2024-2029 (%)
Data Table on TCA - Year-over-year growth 2024-2029 (%)
8.5 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Route of Administration
9.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
9.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
9.3 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
9.4 Parentral - Market size and forecast 2024-2029
Chart on Parentral - Market size and forecast 2024-2029 ($ million)
Data Table on Parentral - Market size and forecast 2024-2029 ($ million)
Chart on Parentral - Year-over-year growth 2024-2029 (%)
Data Table on Parentral - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by Therapy
10.1 Market segments
Chart on Therapy - Market share 2024-2029 (%)
Data Table on Therapy - Market share 2024-2029 (%)
10.2 Comparison by Therapy
Chart on Comparison by Therapy
Data Table on Comparison by Therapy
10.3 Cognitive behavioral therapy - Market size and forecast 2024-2029
Chart on Cognitive behavioral therapy - Market size and forecast 2024-2029 ($ million)
Data Table on Cognitive behavioral therapy - Market size and forecast 2024-2029 ($ million)
Chart on Cognitive behavioral therapy - Year-over-year growth 2024-2029 (%)
Data Table on Cognitive behavioral therapy - Year-over-year growth 2024-2029 (%)
10.4 Augmentation therapy - Market size and forecast 2024-2029
Chart on Augmentation therapy - Market size and forecast 2024-2029 ($ million)
Data Table on Augmentation therapy - Market size and forecast 2024-2029 ($ million)
Chart on Augmentation therapy - Year-over-year growth 2024-2029 (%)
Data Table on Augmentation therapy - Year-over-year growth 2024-2029 (%)
10.5 Aversion therapy - Market size and forecast 2024-2029
Chart on Aversion therapy - Market size and forecast 2024-2029 ($ million)
Data Table on Aversion therapy - Market size and forecast 2024-2029 ($ million)
Chart on Aversion therapy - Year-over-year growth 2024-2029 (%)
Data Table on Aversion therapy - Year-over-year growth 2024-2029 (%)
10.6 Systematic desensitization - Market size and forecast 2024-2029
Chart on Systematic desensitization - Market size and forecast 2024-2029 ($ million)
Data Table on Systematic desensitization - Market size and forecast 2024-2029 ($ million)
Chart on Systematic desensitization - Year-over-year growth 2024-2029 (%)
Data Table on Systematic desensitization - Year-over-year growth 2024-2029 (%)
10.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
10.8 Market opportunity by Therapy
Market opportunity by Therapy ($ million)
Data Table on Market opportunity by Therapy ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.10 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.11 Mexico - Market size and forecast 2024-2029
Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Chart on Mexico - Year-over-year growth 2024-2029 (%)
Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.12 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.13 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.14 The Netherlands - Market size and forecast 2024-2029
Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
12.15 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.16 Spain - Market size and forecast 2024-2029
Chart on Spain - Market size and forecast 2024-2029 ($ million)
Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Chart on Spain - Year-over-year growth 2024-2029 (%)
Data Table on Spain - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Alembic Ltd.
Alembic Ltd. - Overview
Alembic Ltd. - Product/Service
Alembic Ltd. - Key offerings
SWOT
15.5 Anant Pharmaceuticals Pvt. Ltd.
Anant Pharmaceuticals Pvt. Ltd. - Overview
Anant Pharmaceuticals Pvt. Ltd. - Product/Service
Anant Pharmaceuticals Pvt. Ltd. - Key offerings
SWOT
15.6 Apotex Inc.
Apotex Inc. - Overview
Apotex Inc. - Product/Service
Apotex Inc. - Key news
Apotex Inc. - Key offerings
SWOT
15.7 BrainsWay Ltd.
BrainsWay Ltd. - Overview
BrainsWay Ltd. - Product/Service
BrainsWay Ltd. - Key offerings
SWOT
15.8 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product/Service
Eli Lilly and Co. - Key offerings
SWOT
15.9 Eridanus Healthcare
Eridanus Healthcare - Overview
Eridanus Healthcare - Product/Service
Eridanus Healthcare - Key offerings
SWOT
15.10 Flamingo Pharmaceuticals Ltd.
Flamingo Pharmaceuticals Ltd. - Overview
Flamingo Pharmaceuticals Ltd. - Product/Service
Flamingo Pharmaceuticals Ltd. - Key offerings
SWOT
15.11 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
SWOT
15.12 H Lundbeck AS
H Lundbeck AS - Overview
H Lundbeck AS - Product/Service
H Lundbeck AS - Key offerings
SWOT
15.13 Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc - Overview
Jazz Pharmaceuticals Plc - Product/Service
Jazz Pharmaceuticals Plc - Key news
Jazz Pharmaceuticals Plc - Key offerings
SWOT
15.14 Lepu Medical Technology Beijing Co. Ltd.
Lepu Medical Technology Beijing Co. Ltd. - Overview
Lepu Medical Technology Beijing Co. Ltd. - Product/Service
Lepu Medical Technology Beijing Co. Ltd. - Key offerings
SWOT
15.15 Lifecare Neuro Products Ltd.
Lifecare Neuro Products Ltd. - Overview
Lifecare Neuro Products Ltd. - Product/Service
Lifecare Neuro Products Ltd. - Key offerings
SWOT
15.16 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.17 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product/Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.18 Wellona Pharma
Wellona Pharma - Overview
Wellona Pharma - Product/Service
Wellona Pharma - Key offerings
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Obsessive-Compulsive Disorder Drugs Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Product - Market share 2024-2029 (%)
Exhibits 39: Data Table on Product - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Product
Exhibits 41: Data Table on Comparison by Product
Exhibits 42: Chart on SSRI - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on SSRI - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on SSRI - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on SSRI - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on TCA - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on TCA - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on TCA - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on TCA - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 54: Market opportunity by Product ($ million)
Exhibits 55: Data Table on Market opportunity by Product ($ million)
Exhibits 56: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 57: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 58: Chart on Comparison by Route of Administration
Exhibits 59: Data Table on Comparison by Route of Administration
Exhibits 60: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 64: Chart on Parentral - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Data Table on Parentral - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Chart on Parentral - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on Parentral - Year-over-year growth 2024-2029 (%)
Exhibits 68: Market opportunity by Route of Administration ($ million)
Exhibits 69: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 70: Chart on Therapy - Market share 2024-2029 (%)
Exhibits 71: Data Table on Therapy - Market share 2024-2029 (%)
Exhibits 72: Chart on Comparison by Therapy
Exhibits 73: Data Table on Comparison by Therapy
Exhibits 74: Chart on Cognitive behavioral therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 75: Data Table on Cognitive behavioral therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 76: Chart on Cognitive behavioral therapy - Year-over-year growth 2024-2029 (%)
Exhibits 77: Data Table on Cognitive behavioral therapy - Year-over-year growth 2024-2029 (%)
Exhibits 78: Chart on Augmentation therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Augmentation therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Augmentation therapy - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Augmentation therapy - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on Aversion therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Aversion therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Aversion therapy - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Aversion therapy - Year-over-year growth 2024-2029 (%)
Exhibits 86: Chart on Systematic desensitization - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Systematic desensitization - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Systematic desensitization - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Systematic desensitization - Year-over-year growth 2024-2029 (%)
Exhibits 90: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 92: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 93: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 94: Market opportunity by Therapy ($ million)
Exhibits 95: Data Table on Market opportunity by Therapy ($ million)
Exhibits 96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 97: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 98: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 99: Chart on Geographic comparison
Exhibits 100: Data Table on Geographic comparison
Exhibits 101: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibits 157: Market opportunity By Geographical Landscape ($ million)
Exhibits 158: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 159: Impact of drivers and challenges in 2024 and 2029
Exhibits 160: Overview on criticality of inputs and factors of differentiation
Exhibits 161: Overview on factors of disruption
Exhibits 162: Impact of key risks on business
Exhibits 163: Companies covered
Exhibits 164: Company ranking index
Exhibits 165: Matrix on companies position and classification
Exhibits 166: Alembic Ltd. - Overview
Exhibits 167: Alembic Ltd. - Product/Service
Exhibits 168: Alembic Ltd. - Key offerings
Exhibits 169: SWOT
Exhibits 170: Anant Pharmaceuticals Pvt. Ltd. - Overview
Exhibits 171: Anant Pharmaceuticals Pvt. Ltd. - Product/Service
Exhibits 172: Anant Pharmaceuticals Pvt. Ltd. - Key offerings
Exhibits 173: SWOT
Exhibits 174: Apotex Inc. - Overview
Exhibits 175: Apotex Inc. - Product/Service
Exhibits 176: Apotex Inc. - Key news
Exhibits 177: Apotex Inc. - Key offerings
Exhibits 178: SWOT
Exhibits 179: BrainsWay Ltd. - Overview
Exhibits 180: BrainsWay Ltd. - Product/Service
Exhibits 181: BrainsWay Ltd. - Key offerings
Exhibits 182: SWOT
Exhibits 183: Eli Lilly and Co. - Overview
Exhibits 184: Eli Lilly and Co. - Product/Service
Exhibits 185: Eli Lilly and Co. - Key offerings
Exhibits 186: SWOT
Exhibits 187: Eridanus Healthcare - Overview
Exhibits 188: Eridanus Healthcare - Product/Service
Exhibits 189: Eridanus Healthcare - Key offerings
Exhibits 190: SWOT
Exhibits 191: Flamingo Pharmaceuticals Ltd. - Overview
Exhibits 192: Flamingo Pharmaceuticals Ltd. - Product/Service
Exhibits 193: Flamingo Pharmaceuticals Ltd. - Key offerings
Exhibits 194: SWOT
Exhibits 195: GlaxoSmithKline Plc - Overview
Exhibits 196: GlaxoSmithKline Plc - Business segments
Exhibits 197: GlaxoSmithKline Plc - Key news
Exhibits 198: GlaxoSmithKline Plc - Key offerings
Exhibits 199: GlaxoSmithKline Plc - Segment focus
Exhibits 200: SWOT
Exhibits 201: H Lundbeck AS - Overview
Exhibits 202: H Lundbeck AS - Product/Service
Exhibits 203: H Lundbeck AS - Key offerings
Exhibits 204: SWOT
Exhibits 205: Jazz Pharmaceuticals Plc - Overview
Exhibits 206: Jazz Pharmaceuticals Plc - Product/Service
Exhibits 207: Jazz Pharmaceuticals Plc - Key news
Exhibits 208: Jazz Pharmaceuticals Plc - Key offerings
Exhibits 209: SWOT
Exhibits 210: Lepu Medical Technology Beijing Co. Ltd. - Overview
Exhibits 211: Lepu Medical Technology Beijing Co. Ltd. - Product/Service
Exhibits 212: Lepu Medical Technology Beijing Co. Ltd. - Key offerings
Exhibits 213: SWOT
Exhibits 214: Lifecare Neuro Products Ltd. - Overview
Exhibits 215: Lifecare Neuro Products Ltd. - Product/Service
Exhibits 216: Lifecare Neuro Products Ltd. - Key offerings
Exhibits 217: SWOT
Exhibits 218: Novartis AG - Overview
Exhibits 219: Novartis AG - Business segments
Exhibits 220: Novartis AG - Key news
Exhibits 221: Novartis AG - Key offerings
Exhibits 222: Novartis AG - Segment focus
Exhibits 223: SWOT
Exhibits 224: Pfizer Inc. - Overview
Exhibits 225

Executive Summary

The following companies are recognized as the key players in the global obsessive-compulsive disorder drugs market: Alembic Ltd., Anant Pharmaceuticals Pvt. Ltd., Apotex Inc., BrainsWay Ltd., Dellwich Healthcare LLP, Eli Lilly and Co., Eridanus Healthcare, Flamingo Pharmaceuticals Ltd., GlaxoSmithKline Plc, H Lundbeck AS, Jabs Biotech Pvt. Ltd., Jazz Pharmaceuticals Plc, Kabir Life Sciences, Lepu Medical Technology Beijing Co. Ltd., Lifecare Neuro Products Ltd., Novartis AG, Pfizer Inc., and Wellona Pharma.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increased use of off-label therapies."

According to the report, one of the major drivers for this market is the rising prevalence of ocd.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alembic Ltd.
  • Anant Pharmaceuticals Pvt. Ltd.
  • Apotex Inc.
  • BrainsWay Ltd.
  • Dellwich Healthcare LLP
  • Eli Lilly and Co.
  • Eridanus Healthcare
  • Flamingo Pharmaceuticals Ltd.
  • GlaxoSmithKline Plc
  • H Lundbeck AS
  • Jabs Biotech Pvt. Ltd.
  • Jazz Pharmaceuticals Plc
  • Kabir Life Sciences
  • Lepu Medical Technology Beijing Co. Ltd.
  • Lifecare Neuro Products Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Wellona Pharma

Related Topics

Related Reports

Obsessive-Compulsive Disorder Drugs Market by Type, Application - Global Forecast 2025-2030 - Product Image

Obsessive-Compulsive Disorder Drugs Market by Type, Application - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Obsessive-Compulsive Disorder Drugs Market by Sub-Type, by Drugs, by Route of Administration, by Population Type, by End-user, and by Region - Product Image

Obsessive-Compulsive Disorder Drugs Market by Sub-Type, by Drugs, by Route of Administration, by Population Type, by End-user, and by Region

  • Report
  • 200 Pages
  • Global
From
Obsessive Compulsive Disorder - Pipeline Insight, 2024 - Product Image

Obsessive Compulsive Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
Obsessive-Compulsive Disorder Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Obsessive-Compulsive Disorder Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 85 Pages
  • Global
From
Obsessive Compulsive Disorder. Current Science and Clinical Practice. Edition No. 1. World Psychiatric Association - Product Image

Obsessive Compulsive Disorder. Current Science and Clinical Practice. Edition No. 1. World Psychiatric Association

  • Book
  • 360 Pages
  • Global
Copyright © 2002-2025 Research and Markets. All Rights Reserved.